Status:
RECRUITING
Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood Component Use in Patients With Cirrhosis of Liver With Non-variceal Bleeding.
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study is aim to compare ROTEM and TEG guided coagulopathy correction in cirrhosis with non- variceal bleed.There are no other study in literature to compare this two group in cirrhosis with non-v...
Detailed Description
AIM:- To compare Rotational thrombo- elastometry vs Thrombo- elastography as a guide for blood component transfusion in patients of Cirrhosis with nonvariceal bleeding. Methodology:- After fulfilling...
Eligibility Criteria
Inclusion
- Patients with Cirrhosis of any etiology
- Age between 18 and 80 years;
- Presenting with nonvariceal upper GI bleeding (diagnosed after doing upper GI endoscopy, which showed ongoing
- bleed form a nonvariceal source); and
- Significant coagulopathy assessed by CCTs (INR \> 1.8 and/or PLTs \< 50 × 109/L).
Exclusion
- Variceal bleed
- Post Variceal ligation ulcer bleed
- Previous or current thrombotic events defined as any documented blood clot in a venous or arterial vessel;
- Anti-PLT or anticoagulant therapy at the time of enrollment or that had been discontinued less than 7 days before evaluation for the study;
- Pregnancy
- Significant cardiopulmonary diseases.
Key Trial Info
Start Date :
December 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06153082
Start Date
December 16 2023
End Date
December 31 2024
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Saurav Paul
New Delhi, National Capital Territory of Delhi, India, 110070